- Home
- RNXT vs KORE Comparison
RNXT vs KORE Comparison
Compare RNXT & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- KORE
- Stock Information
- Founded
- RNXT 2012
- KORE 2003
- Country
- RNXT United States
- KORE United States
- Employees
- RNXT N/A
- KORE N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- KORE Telecommunications Equipment
- Sector
- RNXT Health Care
- KORE Consumer Discretionary
- Exchange
- RNXT Nasdaq
- KORE Nasdaq
- Market Cap
- RNXT 44.6M
- KORE 45.0M
- IPO Year
- RNXT 2021
- KORE N/A
- Fundamental
- Price
- RNXT $1.36
- KORE $2.30
- Analyst Decision
- RNXT Strong Buy
- KORE Hold
- Analyst Count
- RNXT 2
- KORE 2
- Target Price
- RNXT $7.25
- KORE $2.75
- AVG Volume (30 Days)
- RNXT 190.7K
- KORE 16.0K
- Earning Date
- RNXT 08-12-2025
- KORE 08-14-2025
- Dividend Yield
- RNXT N/A
- KORE N/A
- EPS Growth
- RNXT N/A
- KORE N/A
- EPS
- RNXT N/A
- KORE N/A
- Revenue
- RNXT $240,000.00
- KORE $282,254,000.00
- Revenue This Year
- RNXT $3,186.05
- KORE $4.66
- Revenue Next Year
- RNXT $291.93
- KORE $6.71
- P/E Ratio
- RNXT N/A
- KORE N/A
- Revenue Growth
- RNXT N/A
- KORE N/A
- 52 Week Low
- RNXT $0.75
- KORE $1.10
- 52 Week High
- RNXT $1.69
- KORE $4.88
- Technical
- Relative Strength Index (RSI)
- RNXT 58.97
- KORE 44.65
- Support Level
- RNXT $1.26
- KORE $2.22
- Resistance Level
- RNXT $1.40
- KORE $2.49
- Average True Range (ATR)
- RNXT 0.05
- KORE 0.19
- MACD
- RNXT -0.01
- KORE -0.02
- Stochastic Oscillator
- RNXT 48.70
- KORE 12.13
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.